Anthropic has filed for a US stock-market listing that could become the largest IPO on record, while warning investors that advanced AI may pose catastrophic or existential risks. The Claude developer’s filing lays out rapid revenue growth, heavy losses and major safety, legal and infrastructure challenges—putting the risks and rewards of the AI boom on display.
Key takeaways
- Anthropic plans to list on Nasdaq under the ticker ANT, but has not disclosed the offer price or share count.
- Reports suggest the company could seek a valuation of up to $2 trillion and raise as much as $100 billion; neither figure is final.
- Its filing warns that powerful AI could cause severe harm if misused or operated without adequate safeguards.
For Power AI Media readers, the listing is more than a financial milestone: it brings AI safety, commercial pressure and public accountability into the same debate.
A record-setting listing in prospect
The five-year-old company, founded by chief executive Dario Amodei, his sister Daniela and five others, is positioning itself to go public ahead of rival OpenAI. If the reported fundraising target is reached, the offering would exceed the $86 billion raised by SpaceX in June. A debut is expected soon, though Anthropic has not confirmed a date or final valuation. Its private valuation was reported at $965 billion earlier this year, while estimates for the IPO have ranged as high as $2 trillion.
The filing reported $16.3 billion in revenue for the first half of 2026 and a net loss of $80.7 billion. Much of that loss reflected accounting changes in the value of convertible bonds, according to reports; the company’s underlying losses were substantially lower. Even so, the scale of spending and the need to keep investing in computing infrastructure raise questions about how quickly AI businesses can turn growth into sustainable profits.
Safety warnings alongside commercial ambitions
Anthropic told investors that advanced systems could pose catastrophic or existential risks if developed or deployed without effective safeguards, oversight and security. It identified potential misuse, replication, weaponisation and high levels of autonomy as particular concerns. The filing also describes possible regulatory action and uncertainty over the company’s liability when its models cause harm.
The warnings sit alongside a commercial case for AI’s potential to accelerate research, medicine and productivity. Anthropic has also said that increasingly capable models could help address diseases and create economic growth. Power AI Media’s coverage spans these applications as well as the social and policy questions they raise: the filing makes clear that progress and risk are being pursued together.
Investors face questions beyond valuation
The IPO will test whether public-market investors are willing to finance the vast costs of developing frontier AI. Anthropic depends on a concentrated network of cloud providers, chipmakers and data centres, leaving its business exposed to supply constraints as well as competition. Its filing also acknowledges that its growth may slow and that further funding could be needed.
Governance is another point of interest. The company’s structure gives its founders substantial voting power, while a Long-Term Benefit Trust is intended to help protect its public-benefit mission. Investors will have to weigh those arrangements against the company’s warnings about safety, financial uncertainty and the consequences of losing the race to build leading AI systems.